The move comes at a time when Omicron and its sub-variants have remained the dominant strains in circulation for close to two years now. Most of the vaccines available and administered in......
The Drugs Controller General of India on Tuesday approved India's first indigenously developed mRNA vaccine against COVID-19 manufactured by Gennova Biopharmaceuticals for restricted emergency use......
The country's first messenger mRNA vaccine is expected to begin trials on humans in February. IMAGE: A health worker administers a dose of COVID-19 vaccine to a beneficiary during a vaccination......
Gennova has also got permission for phase-2 and 3 clinical trials for its lyophilised mRNA vaccine for injection from the subject expert committee advising the Central Drugs Standards Control......
If things go according to plan, the vaccine would be available in the market by the end of this year. IMAGE: Kindly note that this image has been posted for representational purposes only.......